Hypersomnolence, a broad presentation encompassing excessive daytime sleepiness,
hypersomnia and sleep inertia, affects around 25% of patients with a major depressive …

This state-of-the-art review explores the relationship between depression and diabetes,
highlighting the two-way influences that make treatment challenging and worsen the …

Intravenous (IV) ketamine and intranasal (IN) esketamine are novel therapies to manage
treatment resistant depression within major depressive disorder (MDD-TRD). This is a multi …

It is time for a paradigm shift in psychiatry. The need for biologically based models to
understand clinical heterogeneity is gaining momentum. Integrating the microbiome into …

Background Bilateral repetitive transcranial magnetic stimulation (BL-rTMS) over the
dorsolateral prefrontal cortex is effective for treatment-resistant depression (TRD). Owing to …

Background Mental health disorders significantly impact global populations, prompting the
rise of digital mental health interventions, such as artificial intelligence (AI)-powered …

Background Pharmacologic management of mental health illnesses in patients receiving
dialysis is complex and lacking data. Objective Our objective was to synthesize published …

In the Sustainable Development Goals of the United Nations for 2030, mental health has
been identified as a global priority, emphasizing the need to reduce the prevalence …

People with severe mental disorders experience premature mortality compared with the
general population. Several factors contribute to the mortality gap, including the adoption of …

Background/Objectives: Suicide accounts for 1.4% of global deaths, and the slow-acting
nature of traditional treatments for suicide risk underscores the need for alternatives …